A listing of lauren-perrey-moore medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
What is the purpose of this study?Dominantly inherited Alzheimer's disease (AD) represents less than 1% of all cases of AD and is an important model for study because the responsible mutations have known biochemical consequences that are believed to underlie the pathological basis of the disorder. The overall purpose of …
Who is Eligible Ages 18+ Must have had symptoms of Alzheimer’s disease prior to age 65 Diagnosis of Alzheimer’s disease Must be able to complete MRI Must be able to tolerate lumbar puncture No history of seizures, stroke or cancer in the last 5 years What is Involved In-person visits …
Who is Eligible Ages 18-80 Diagnosis of ALS with symptoms starting less than 18 months ago Able to swallow medication capsules No history of cancer within last 5 years No use of tracheostomy or almost continuous ventilator support What is Invovled In-person appointments at the IUH Neuroscience Center Participants will …
The purpose of this study is to collect clinical information about patients and families with Huntington Disease. Who is Eligible Diagnosis of Huntington’s disease What is Involved In person at IUH Neuroscience Center Annual cognitive testing and blood work at routine clinic appointment.
We are doing this research to test a new method of diagnosing Alzheimer’s Disease using a blood test and an injection of a diabetes drug called pramlintide. You will receive one dose of this medication at each of two visits. This study is conducted at three medical centers in Indianapolis …
Who is EligibleAges 18+Diagnosis of Parkinson’s diseaseWillingness to undergo genetic testingWhat is InvolvedIn person at IUH Neuroscience Center or kit can be mailed to participant’s homeGenetic testing occurs via buccal swab or blood draw in clinic or at home, participants receive genetic counseling
What is the purpose of this study?The primary objective of this study is to collect data on the penetration of commercially available, FDA approved, extended-release niacin into the spinal fluid. One dose of 500 mg nicotinic acid will be used (in addition to placebo) to build a dose response curve …
Who is Eligible Ages 35-55 Must be willing to complete PET scan What is Involved Onsite visits at the IUH Neuroscience Center Visits at the IUH Neuroscience Center every 16 months Compensation Compensation available via payment card for each completed appointment
